ICU感染鲍曼不动杆菌的病例特征分析  

Analysis of the characteristics Acinetobacter baumanii infection in ICU patients

作　　者：鲁厚清[1] 吴忠展[1] 邵仁德[1] 汪洋[1] 汪文杰[1] 

机构地区：[1]皖南医学院附属铜陵市人民医院重症医学科,安徽铜陵244000

出　　处：《现代预防医学》2012年第20期5382-5383,共2页Modern Preventive Medicine

摘　　要：目的了解鲍曼不动杆菌感染的危险因素与耐药的现状。方法选择70例鲍曼不动杆菌感染的患者,回顾分析其感染及耐药性的变化。结果 70例患者中,存活51例(72.9%),死亡19例(27.1%)。感染部位主要是呼吸道(68.5%)和伤口(8.5%),且对多种抗生素耐药。结论危重症患者是鲍曼不动杆菌的易感人群;鲍曼不动杆菌对常用抗菌药物的耐药率高,多重耐药现象严重,应加强细菌耐药性监测,根据药敏结果选择单一或联用抗菌药物,有效控制和减缓细菌耐药性的增长。OBJECTIVE To investigate the information about the present nosocomial infection characteristics and drug resis tance of Acinetobacter baumanii （Ab）. METHODS 70 patients with Ab infection in patients, retrospective analysis of infection and resistance changes. RESULTS Among 70 patients, 51 patients survived （72.9%）, and 19 patients died （27.1%）. Sites of infection were mainly respiratory （68.5%） and wound （8.5%）, and resistant to many antibiotics. CONCLUSION The critical ly ill patients are the high risk population of Ab; Ab resistant to commonly used antibiotics is high, and there was a serious multi-drug resistance. It is necessary to strengthen the bacterial resistance surveillance based on susceptibility results, choose a single or in combination with antimicrobial agents to effective control and slow down the growth of bacterial resistance.

关 键 词：鲍曼不动杆菌 ICU感染 耐药性 

分 类 号：R373[医药卫生—病原生物学]